Reaction

Cerebral Venous Sinus Thrombosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 809 reports · 22 co-occurring drugs

As of the last recalculation, Cerebral Venous Sinus Thrombosis appears in 809 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is PEGASPARGASE (PRR 70.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Pegaspargase3270.070.2
Tranexamic Acid2162.362.5
Heparin Sodium2548.248.3
Dexamethasone Sodium Phosphate1846.646.7
Eltrombopag Olamine2933.533.6
Romiplostim1933.233.3
Human Immunoglobulin G2126.926.9
Mercaptopurine1624.224.2
Tofacitinib Citrate1121.921.9
Cholestyramine919.419.4
Dutasteride619.119.1
Testosterone1719.119.1
Amphetamine515.615.6
Baricitinib513.413.4
Etonogestrel And Ethinyl Estradiol1112.912.9
Axicabtagene Ciloleucel410.510.5
Cenobamate39.39.3
Abemaciclib67.87.8
Remdesivir47.87.8
Daratumumab117.27.2
Canagliflozin86.96.9
Drospirenone And Ethinyl Estradiol105.95.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.